The revenue stands at ₹702.70 crore, reflecting a quarter-on-quarter *(QoQ) increase of 6.50 per cent from ₹659.80 crore. This corresponds to a year-on-year *(YoY) growth of 16.61 per cent.
Operating Profit stands at ₹186.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 25.20 per cent from ₹149.20 crore. This corresponds to a year-on-year *(YoY) growth of 10.53 per cent.
PBDT stands at ₹204.70 crore, reflecting a quarter-on-quarter *(QoQ) increase of 23.02 per cent from ₹166.40 crore. This corresponds to a year-on-year *(YoY) growth of 7.85 per cent.
Profit Before Tax stands at ₹160.10 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.80 per cent from ₹124.30 crore. This corresponds to a year-on-year *(YoY) growth of 4.37 per cent.
Net Profit stands at ₹132.20 crore, reflecting a quarter-on-quarter *(QoQ) increase of 44.64 per cent from ₹91.40 crore. This represents a 14.98 per cent year-on-year *(YoY) decline for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Dr Lal Pathlabs | 1.30% | -3.42% | 12.98% | 12.14% | 1.02% | 13.91% |
| Narayana Hrudaya | -0.46% | -3.21% | 3.04% | -0.49% | -6.22% | 3.14% |
| Global Health | 0.86% | -2.32% | 10.63% | 5.70% | 1.69% | 0.64% |
| Krishna Institu. | -0.94% | -1.05% | 15.99% | 12.64% | 15.46% | 20.63% |
| Syngene Intl. | 1.29% | -2.38% | 8.35% | 8.28% | -26.73% | -26.99% |
| Poly Medicure | -3.22% | -6.32% | 3.23% | 18.76% | -18.58% | -36.07% |
| Dr Agarwal's Hea | -0.36% | -3.81% | -0.58% | -1.76% | -12.00% | 12.25% |
Chairman cum Managing Director : Arvind Lal
Whole-time Director : Vandana Lal
Whole Time Director & CEO : Om Prakash Manchanda
Director : Rahul Sharma
Independent Director : Arun Duggal
Independent Director : Anoop Mahendra Singh
Independent Director : Sunil Varma
Independent Director : Harneet Singh Chandhoke
Independent Director : Saurabh Srivastava
Company Secretary : Rajat Kalra